发明公开
EP3170834A1 CRYSTALLINE FORMS OF (1S,3'R,4'S,5'S,6'R)-6-[(4-ETHYLPHENYL)METHYL]-3',4',5',6'-TETRAHYDRO-6'- (HYDROXYMETHYL)SPIRO[ISOBENZOFURAN-1(3H) 2'-[2H]PYRAN]-3',4',5'-TRIOL 审中-公开
(1S,3'R,4'S,5'S,6'R)-6 - [(4-乙基苯基)甲基] -3',4',5',6'-四氢-6' - (羟基甲基) SPIRO [异苯并呋喃-1(3H)2' - [2H]吡喃] -3',4',5'-三醇

CRYSTALLINE FORMS OF (1S,3'R,4'S,5'S,6'R)-6-[(4-ETHYLPHENYL)METHYL]-3',4',5',6'-TETRAHYDRO-6'- (HYDROXYMETHYL)SPIRO[ISOBENZOFURAN-1(3H) 2'-[2H]PYRAN]-3',4',5'-TRIOL
摘要:
The present invention relates to crystalline forms of the compound represented by Formula (XI), which is useful for preventing or treating diabetes.
信息查询
0/0